A/APublished research associates this genotype with typical/baseline likelihood of Body mass index (change over time) — no copies of the reported risk allele.
A/GPublished research associates this genotype (one copy of the reported risk allele) with an intermediate association with Body mass index (change over time).
G/GPublished research associates this genotype (two copies of the reported risk allele) with a higher likelihood of Body mass index (change over time) compared to the general population.
rs347313 is a single position in the genome, in or near the NOS1AP gene. Published research associates it with body mass index (change over time). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.
What conditions is rs347313 linked to?
On MyGeneLog this position is linked to Obesity and Body Weight. The research behind each link, and its sources, are set out on that condition page.
Does rs347313 affect how medicines work?
NOS1AP carries pharmacogenomic findings for QT-prolonging medicines. That is educational information, not a prescription or a dosing guide. Any decision to start, stop or change a medicine belongs with the clinician or pharmacist managing your treatment.
Does having rs347313 mean I will get this?
No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.
Where does the information about rs347313 come from?
GWAS Catalog, PLoS One 2014, PMID:25133637. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.